Terms: = Pancreatic cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC
44 results:
1. Surgeon-Dependent Variability in Cost of Gastrointestinal Operations in a Single cancer Center.
Sarkar J; Roehner RP; Proulx MJ; Schwarz RE
J Surg Res; 2024 Mar; 295():666-672. PubMed ID: 38113610
[TBL] [Abstract] [Full Text] [Related]
2. FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world.
Marschner N; Hegewisch-Becker S; Reiser M; von der Heyde E; Bertram M; Hollerbach SH; Kreher S; Wolf T; Binninger A; Chiabudini M; Kaiser-Osterhues A; Jänicke M;
Int J Cancer; 2023 Feb; 152(3):458-469. PubMed ID: 36053905
[TBL] [Abstract] [Full Text] [Related]
3. Robotic pancreaticoduodenectomy: Increased Adoption and Improved Outcomes: Is Laparoscopy Still Justified?
Khachfe HH; Nassour I; Hammad AY; Hodges JC; AlMasri S; Liu H; deSilva A; Kraftician J; Lee KK; Pitt HA; Zureikat AH; Paniccia A
Ann Surg; 2023 Sep; 278(3):e563-e569. PubMed ID: 36000753
[TBL] [Abstract] [Full Text] [Related]
4. International trends in esophageal cancer incidence rates by histological subtype (1990-2012) and prediction of the rates to 2030.
Lin Y; Wang HL; Fang K; Zheng Y; Wu J
Esophagus; 2022 Oct; 19(4):560-568. PubMed ID: 35689719
[TBL] [Abstract] [Full Text] [Related]
5. Fructose-1,6-bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinoma.
Damanakis A; Plum PS; Gebauer F; Schröder W; Büttner R; Zander T; Bruns CJ; Quaas A
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2287-2293. PubMed ID: 35477823
[TBL] [Abstract] [Full Text] [Related]
6. Trefoil factor 1 inhibits the development of esophageal adenocarcinoma from Barrett's epithelium.
Hasebe K; Yamazaki K; Yamaguchi J; Kokuryo T; Yokoyama Y; Miyata K; Fukaya M; Nagino M; Ebata T
Lab Invest; 2022 Aug; 102(8):885-895. PubMed ID: 35279702
[TBL] [Abstract] [Full Text] [Related]
7. Fruit and vegetable consumption and risk of esophageal cancer in the Asian region: a systematic review and meta-analysis.
Sakai M; Kitagawa Y; Saeki H; Miyazaki T; Yamaji T; Nemoto K; Oyama T; Muto M; Takeuchi H; Toh Y; Matsubara H; Mano M; Kono K; Kato K; Yoshida M; Kawakubo H; Booka E; Yamatsuji T; Kato H; Ito Y; Ishikawa H; Ishihara R; Tsushima T; Kawachi H; Oyama T; Kojima T; Kuribayashi S; Makino T; Matsuda S; Sohda M; Kubo Y; Doki Y;
Esophagus; 2022 Jan; 19(1):27-38. PubMed ID: 34561813
[TBL] [Abstract] [Full Text] [Related]
8. Massively Parallel Sequencing of Esophageal Brushings Enables an Aneuploidy-Based Classification of Patients With Barrett's Esophagus.
Douville C; Moinova HR; Thota PN; Shaheen NJ; Iyer PG; Canto MI; Wang JS; Dumot JA; Faulx A; Kinzler KW; Papadopoulos N; Vogelstein B; Markowitz SD; Bettegowda C; Willis JE; Chak A
Gastroenterology; 2021 May; 160(6):2043-2054.e2. PubMed ID: 33493502
[TBL] [Abstract] [Full Text] [Related]
9. Optimization of Immunophenotypic Panel to Differentiate Upper From Lower Gastrointestinal Adenocarcinomas: Analysis of New and Traditional Markers.
Chauhan A; Sanchez-Avila M; Manivel J; Dachel S; Larson W; Hanson B; Gravely A; Mesa H
Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):13-19. PubMed ID: 33295746
[TBL] [Abstract] [Full Text] [Related]
10. Cytopathological Heterogeneity of Circulating Tumor Cells in Non-metastatic Esophageal Adenocarcinoma.
Kuvendjiska J; Pitman MB; Martini V; Braun C; Grebe K; Timme S; Fichtner-Feigl S; Glatz T; Schmoor C; Guenzle J; Hoeppner J; Kulemann B
Anticancer Res; 2020 Oct; 40(10):5679-5685. PubMed ID: 32988893
[TBL] [Abstract] [Full Text] [Related]
11. Outcome of a novel modified endoscopic papillectomy for duodenal major papilla adenoma.
Wang P; Jiang C; Wang Y; Zhou L; Zhang S; Ding X; Lv Y; Wang L; Zou X
Surg Endosc; 2020 Nov; 34(11):5160-5167. PubMed ID: 32666256
[TBL] [Abstract] [Full Text] [Related]
12. Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the cyld/RIPK1/FADD/caspase-8-dependent apoptosis.
Yang C; Ran Q; Zhou Y; Liu S; Zhao C; Yu X; Zhu F; Ji Y; Du Q; Yang T; Zhang W; He S
Apoptosis; 2020 Jun; 25(5-6):441-455. PubMed ID: 32418059
[TBL] [Abstract] [Full Text] [Related]
13. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses.
Molina-Montes E; Coscia C; Gómez-Rubio P; Fernández A; Boenink R; Rava M; Márquez M; Molero X; Löhr M; Sharp L; Michalski CW; Farré A; Perea J; O'Rorke M; Greenhalf W; Iglesias M; Tardón A; Gress TM; Barberá VM; Crnogorac-Jurcevic T; Muñoz-Bellvís L; Dominguez-Muñoz JE; Renz H; Balcells J; Costello E; Ilzarbe L; Kleeff J; Kong B; Mora J; O'Driscoll D; Poves I; Scarpa A; Yu J; Hidalgo M; Lawlor RT; Ye W; Carrato A; Real FX; Malats N;
Gut; 2021 Feb; 70(2):319-329. PubMed ID: 32409590
[TBL] [Abstract] [Full Text] [Related]
14. Intraoperative electrochemotherapy in locally advanced pancreatic cancer: indications, techniques and results-a single-center experience.
Casadei R; Ricci C; Ingaldi C; Alberici L; Di Marco M; Guido A; Minni F; Serra C
Updates Surg; 2020 Dec; 72(4):1089-1096. PubMed ID: 32399592
[TBL] [Abstract] [Full Text] [Related]
15. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.
Săftoiu A; Hassan C; Areia M; Bhutani MS; Bisschops R; Bories E; Cazacu IM; Dekker E; Deprez PH; Pereira SP; Senore C; Capocaccia R; Antonelli G; van Hooft J; Messmann H; Siersema PD; Dinis-Ribeiro M; Ponchon T
Endoscopy; 2020 Apr; 52(4):293-304. PubMed ID: 32052404
[TBL] [Abstract] [Full Text] [Related]
16. Prostate cancer Risk Stratification in Men With a Clinical Suspicion of Prostate cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques.
Montoya Perez I; Jambor I; Pahikkala T; Airola A; Merisaari H; Saunavaara J; Alinezhad S; Väänänen RM; Tallgrén T; Verho J; Kiviniemi A; Ettala O; Knaapila J; Syvänen KT; Kallajoki M; Vainio P; Aronen HJ; Pettersson K; Boström PJ; Taimen P
J Magn Reson Imaging; 2020 May; 51(5):1540-1553. PubMed ID: 31588660
[TBL] [Abstract] [Full Text] [Related]
17. Survivals of patients with surgically treated and High-grade pancreatic neuroendocrine carcinomas: A comparative study between two American Joint Committee on cancer 8th tumor-node-metastasis staging systems.
Yang M; Zhang Y; Zeng L; Ke NW; Tan CL; Tian BL; Xiang B; Liu XB
Eur J Surg Oncol; 2019 Jun; 45(6):1054-1060. PubMed ID: 30661921
[TBL] [Abstract] [Full Text] [Related]
18. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
[TBL] [Abstract] [Full Text] [Related]
19. Rutin and orlistat produce antitumor effects via antioxidant and apoptotic actions.
Saleh A; ElFayoumi HM; Youns M; Barakat W
Naunyn Schmiedebergs Arch Pharmacol; 2019 Feb; 392(2):165-175. PubMed ID: 30465055
[TBL] [Abstract] [Full Text] [Related]
20. cyld deficiency promotes pancreatic cancer development by causing mitotic defects.
Xie S; Wu Y; Hao H; Li J; Guo S; Xie W; Li D; Zhou J; Gao J; Liu M
J Cell Physiol; 2019 Jun; 234(6):9723-9732. PubMed ID: 30362575
[TBL] [Abstract] [Full Text] [Related]
[Next]
